Page last updated: 2024-12-08

4-hydroxyphenylacetaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxyphenylacetaldehyde: the major product of L-tyrosine oxidation by activated human phagocytes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID440113
CHEBI ID15621
SCHEMBL ID105690
MeSH IDM0257246

Synonyms (30)

Synonym
poh-ph-ch2cho
CHEBI:15621
p-hydroxyphenylacetaldehyde
(4-hydroxyphenyl)acetaldehyde
4-hydroxyphenylacetaldehyde
C03765
2-(4-hydroxyphenyl)acetaldehyde
7339-87-9
hpal
FT-0669947
AKOS004120647
2-(4-hydroxyphenyl)-acetaldehyde
benzeneacetaldehyde, 4-hydroxy-
hdj7b4kb3x ,
unii-hdj7b4kb3x
gtpl6635
4-hydroxyphenyl acetaldehyde
SCHEMBL105690
DTXSID00223631
4-hydoxyphenylacetaldehyde
benzeneacetaldehyde,4-hydroxy-
mfcd03411043
J-506016
(4-hydroxy-phenyl)-acetaldehyde
A930614
Q9552908
4-hydroxyphenylacetaldehyde, approximately ~15% wt/vol in ethyl acetate
4-hydroxyphenylacetaldehyde, approximately ~15per cent by weight in ethyl acetate
2-(4-hydroxyphenyl)ethanal
PD049641
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenylacetaldehydes
alpha-CH2-containing aldehydeAn aldehyde of general formula R-CH2-CH=O in which the aldehydic C=O function is attached to a CH2 group at the alpha-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Amine Oxidase reactions419
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB212
salidroside biosynthesis215
(S)-reticuline biosynthesis I030
Tyrosine metabolism ( Tyrosine metabolism )2841
NAD+ + 4-Hydroxy-phenyl-acetaldehyde + H2O = NADH + 4-Hydroxy-phenyl-acetic acid ( Tyrosine metabolism )45
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
aromatic biogenic amine degradation (bacteria)335
L-tyrosine degradation III913
(S)-reticuline biosynthesis I128
tyrosine degradation III1212

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (30.77)18.2507
2000's5 (38.46)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.44 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]